Skip to content
Search AI Powered

Latest Stories

Contraceptive pill Hana wins Innovation of The Year Award, HRA Pharma says

HRA Pharma, one of the leading consumer healthcare companies in the world, today announced its contraceptive pill Hana has won the Innovation of The Year Award at the OTCToolbox Consumer Healthcare Industry (CHi) Awards.

The prescription-free contraceptive pill was also nominated as a finalist in the Regulatory Achievement category.


After a pharmacy consultation, the pill became available for women in the UK without a prescription in July last year, providing easy access of the progestogen-only contraceptive pill.

HANA IMAGE 2

This groundbreaking reclassification from prescription only, to over-the-counter (OTC), made HRA Pharma a leader in this new and significant healthcare category.

Hélène Guillard, global Rx-to-OTC switch director, said, “This reclassification of Hana is a major milestone for women and reinforces our mission at HRA to empower people to improve their lives by developing accessible added-value self-care solutions.

“Our team has made history in Women’s Health once again with the UK being the first Western country to truly offer this type of contraceptive pill without a prescription. We are extremely proud of this achievement and delighted to be recognised by the OTCToolbox Consumer Healthcare Innovation Award.”

Being an early entrant in the new market, Hana has achieved 90 per cent market share since its launch last summer.

David Wright, CEO at HRA Pharma said: “Innovation is an area HRA is heavily invested in. As such, HRA Pharma has become an innovative, award-winning, OTC-focused and rapidly growing company, with direct operational presence in 11 European countries and partnerships that have extended the availability of its products to over 90 countries worldwide.

“The launch of Hana in 2021 was a huge milestone for our Women’s Health team and one we have worked for a long time to achieve. This is only the beginning of what we can do to overhaul the women’s health sector and ensure accessibility and choice for all women across the world”.

Created in 1996, the company aims at providing innovative solutions to medical needs that had not been addressed previously by large pharmaceutical groups.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less